TOBREX is a Ophthalmic Ointment in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Tobramycin.
| Product ID | 0078-0813_5b66bba3-cf97-4a9c-b618-ba5f277f20f6 |
| NDC | 0078-0813 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TOBREX |
| Generic Name | Tobramycin |
| Dosage Form | Ointment |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 1981-06-28 |
| Marketing Category | NDA / |
| Application Number | NDA050555 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | TOBRAMYCIN |
| Active Ingredient Strength | 3 mg/g |
| Pharm Classes | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-03-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0065-0643 | Tobrex | tobramycin |
| 0065-0644 | TOBREX | tobramycin |
| 0078-0813 | TOBREX | tobramycin |
| 21695-458 | Tobrex | Tobrex |
| 10122-820 | BETHKIS | tobramycin |
| 0078-0494 | TOBI | Tobramycin |
| 0078-0630 | TOBI Podhaler | Tobramycin |
| 0093-3750 | Tobramycin | Tobramycin |
| 0093-4085 | Tobramycin | Tobramycin |
| 0404-7196 | Tobramycin | Tobramycin |
| 0409-3578 | TOBRAMYCIN | TOBRAMYCIN |
| 0703-9402 | Tobramycin | Tobramycin |
| 0781-7171 | Tobramycin | Tobramycin |
| 10544-883 | Tobramycin | Tobramycin |
| 13985-604 | Tobramycin | Tobramycin |
| 13985-743 | Tobramycin | Tobramycin |
| 17478-290 | Tobramycin | Tobramycin |
| 17478-340 | Tobramycin | Tobramycin |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TOBREX 73276380 1189092 Live/Registered |
Alcon Laboratories, Inc. 1980-09-02 |